Literature DB >> 23475768

NFAT is required for spontaneous pulmonary hypertension in superoxide dismutase 1 knockout mice.

Juan Manuel Ramiro-Diaz1, Carlos H Nitta, Levi D Maston, Simon Codianni, Wieslawa Giermakowska, Thomas C Resta, Laura V Gonzalez Bosc.   

Abstract

Elevated reactive oxygen species are implicated in pulmonary hypertension (PH). Superoxide dismutase (SOD) limits superoxide bioavailability, and decreased SOD activity is associated with PH. A decrease in SOD activity is expected to increase superoxide and reduce hydrogen peroxide levels. Such an imbalance of superoxide/hydrogen peroxide has been implicated as a mediator of nuclear factor of activated T cells (NFAT) activation in epidermal cells. We have shown that NFATc3 is required for chronic hypoxia-induced PH. However, it is unknown whether NFATc3 is activated in the pulmonary circulation in a mouse model of decreased SOD1 activity and whether this leads to PH. Therefore, we hypothesized that an elevated pulmonary arterial superoxide/hydrogen peroxide ratio activates NFATc3, leading to PH. We found that SOD1 knockout (KO) mice have elevated pulmonary arterial wall superoxide and decreased hydrogen peroxide levels compared with wild-type (WT) littermates. Right ventricular systolic pressure (RVSP) was elevated in SOD1 KO and was associated with pulmonary arterial remodeling. Vasoreactivity to endothelin-1 was also greater in SOD1 KO vs. WT mice. NFAT activity and NFATc3 nuclear localization were increased in pulmonary arteries from SOD1 KO vs. WT mice. Administration of A-285222 (selective NFAT inhibitor) decreased RVSP, arterial wall thickness, vasoreactivity, and NFAT activity in SOD1 KO mice to WT levels. The SOD mimetic, tempol, also reduced NFAT activity, NFATc3 nuclear localization, and RVSP to WT levels. These findings suggest that an elevated superoxide/hydrogen peroxide ratio activates NFAT in pulmonary arteries, which induces vascular remodeling and increases vascular reactivity leading to PH.

Entities:  

Keywords:  chronic hypoxia; endothelin-1; hydrogen peroxide; nuclear factor of activated T cells c3; pulmonary arterial remodeling; pulmonary hypertension; superoxide; vasoreactivity

Mesh:

Substances:

Year:  2013        PMID: 23475768      PMCID: PMC3652021          DOI: 10.1152/ajplung.00408.2012

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  103 in total

1.  Lung extracellular superoxide dismutase overexpression lessens bleomycin-induced pulmonary hypertension and vascular remodeling.

Authors:  Zachary Van Rheen; Cheryl Fattman; Shannon Domarski; Susan Majka; Dwight Klemm; Kurt R Stenmark; Eva Nozik-Grayck
Journal:  Am J Respir Cell Mol Biol       Date:  2010-06-10       Impact factor: 6.914

2.  Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension.

Authors:  C Rubens; R Ewert; M Halank; R Wensel; H D Orzechowski; H P Schultheiss; G Hoeffken
Journal:  Chest       Date:  2001-11       Impact factor: 9.410

3.  Endothelial nitric oxide synthase is essential for postpneumonectomy compensatory vasodilation.

Authors:  Thomas S Maxey; Lucas G Fernandez; T Brett Reece; William B Keeling; Irving L Kron; Victor E Laubach
Journal:  Ann Thorac Surg       Date:  2006-04       Impact factor: 4.330

4.  Increased hydrogen peroxide downregulates soluble guanylate cyclase in the lungs of lambs with persistent pulmonary hypertension of the newborn.

Authors:  Stephen Wedgwood; Robin H Steinhorn; Melisa Bunderson; Jason Wilham; Satyan Lakshminrusimha; Lisa A Brennan; Stephen M Black
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2005-06-03       Impact factor: 5.464

5.  3,5-Bis(trifluoromethyl)pyrazoles: a novel class of NFAT transcription factor regulator.

Authors:  S W Djuric; N Y BaMaung; A Basha; H Liu; J R Luly; D J Madar; R J Sciotti; N P Tu; F L Wagenaar; P E Wiedeman; X Zhou; S Ballaron; J Bauch; Y W Chen; X G Chiou; T Fey; D Gauvin; E Gubbins; G C Hsieh; K C Marsh; K W Mollison; M Pong; T K Shaughnessy; M P Sheets; M Smith; J M Trevillyan; U Warrior; C D Wegner; G W Carter
Journal:  J Med Chem       Date:  2000-08-10       Impact factor: 7.446

6.  Preliminary in vivo pharmacokinetic and pharmacodynamic evaluation of a novel calcineurin-independent inhibitor of NFAT.

Authors:  Tudor Bîrsan; Camille Dambrin; Kennan C Marsh; Wolfgang Jacobsen; Stevan W Djuric; Karl W Mollison; Uwe Christians; George W Carter; Randall E Morris
Journal:  Transpl Int       Date:  2004-01-21       Impact factor: 3.782

7.  Enhanced depolarization-induced pulmonary vasoconstriction following chronic hypoxia requires EGFR-dependent activation of NAD(P)H oxidase 2.

Authors:  Charles E Norton; Brad R S Broughton; Nikki L Jernigan; Benjimen R Walker; Thomas C Resta
Journal:  Antioxid Redox Signal       Date:  2012-10-18       Impact factor: 8.401

8.  Activity-dependent NFATc3 nuclear accumulation in pericytes from cortical parenchymal microvessels.

Authors:  Jessica A Filosa; Mark T Nelson; Laura V Gonzalez Bosc
Journal:  Am J Physiol Cell Physiol       Date:  2007-09-19       Impact factor: 4.249

9.  [Expression of endothelin-1 mRNA, endothelin receptor-A and nitric oxide synthase mRNA in pulmonary artery and right ventriculus cordis of rats exposed to hypoxia].

Authors:  P Ran; J Xu; S Chen
Journal:  Zhonghua Yi Xue Za Zhi       Date:  1995-08

10.  Oxidative stress in severe pulmonary hypertension.

Authors:  Rebecca Bowers; Carlyne Cool; Robert C Murphy; Rubin M Tuder; Matthew W Hopken; Sonia C Flores; Norbert F Voelkel
Journal:  Am J Respir Crit Care Med       Date:  2003-12-30       Impact factor: 21.405

View more
  21 in total

Review 1.  The role of nuclear factor of activated T cells in pulmonary arterial hypertension.

Authors:  Rui Chen; Jinchuan Yan; Peijing Liu; Zhongqun Wang; Cuiping Wang; Wei Zhong; Liangjie Xu
Journal:  Cell Cycle       Date:  2017-01-19       Impact factor: 4.534

2.  Deficiency of superoxide dismutase impairs protein C activation and enhances susceptibility to experimental thrombosis.

Authors:  Sanjana Dayal; Sean X Gu; Ryan D Hutchins; Katina M Wilson; Yi Wang; Xiaoyun Fu; Steven R Lentz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-06-11       Impact factor: 8.311

3.  Central role of T helper 17 cells in chronic hypoxia-induced pulmonary hypertension.

Authors:  Levi D Maston; David T Jones; Wieslawa Giermakowska; Tamara A Howard; Judy L Cannon; Wei Wang; Yongyi Wei; Weimin Xuan; Thomas C Resta; Laura V Gonzalez Bosc
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-02-17       Impact factor: 5.464

4.  Redox Biology of Peroxisome Proliferator-Activated Receptor-γ in Pulmonary Hypertension.

Authors:  Victor Tseng; Roy L Sutliff; C Michael Hart
Journal:  Antioxid Redox Signal       Date:  2019-02-25       Impact factor: 8.401

Review 5.  Paradoxical Roles of Antioxidant Enzymes: Basic Mechanisms and Health Implications.

Authors:  Xin Gen Lei; Jian-Hong Zhu; Wen-Hsing Cheng; Yongping Bao; Ye-Shih Ho; Amit R Reddi; Arne Holmgren; Elias S J Arnér
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

6.  ASIC1-mediated calcium entry stimulates NFATc3 nuclear translocation via PICK1 coupling in pulmonary arterial smooth muscle cells.

Authors:  Laura V Gonzalez Bosc; Danielle R Plomaritas; Lindsay M Herbert; Wieslawa Giermakowska; Carly Browning; Nikki L Jernigan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-05-17       Impact factor: 5.464

7.  Chronic hypoxia limits H2O2-induced inhibition of ASIC1-dependent store-operated calcium entry in pulmonary arterial smooth muscle.

Authors:  Danielle R Plomaritas; Lindsay M Herbert; Tracylyn R Yellowhair; Thomas C Resta; Laura V Gonzalez Bosc; Benjimen R Walker; Nikki L Jernigan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-07-03       Impact factor: 5.464

8.  Intermittent hypoxia-induced increases in reactive oxygen species activate NFATc3 increasing endothelin-1 vasoconstrictor reactivity.

Authors:  J K Friedman; C H Nitta; K M Henderson; S J Codianni; L Sanchez; J M Ramiro-Diaz; T A Howard; W Giermakowska; N L Kanagy; L V Gonzalez Bosc
Journal:  Vascul Pharmacol       Date:  2013-11-15       Impact factor: 5.773

9.  Mechanisms of NFATc3 activation by increased superoxide and reduced hydrogen peroxide in pulmonary arterial smooth muscle.

Authors:  Juan Manuel Ramiro-Diaz; Wieslawa Giermakowska; John M Weaver; Nikki L Jernigan; Laura V Gonzalez Bosc
Journal:  Am J Physiol Cell Physiol       Date:  2014-08-27       Impact factor: 4.249

Review 10.  Mitochondrial dysfunction and pulmonary hypertension: cause, effect, or both.

Authors:  Jeffrey D Marshall; Isabel Bazan; Yi Zhang; Wassim H Fares; Patty J Lee
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-01-18       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.